Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Senti Biosciences Inc (NASDAQ: SNTI) was $2.13 for the day, down -8.19% from the previous closing price of $2.32. In other words, the price has decreased by -$8.19 from its previous closing price. On the day, 42033.0 shares were traded. SNTI stock price reached its highest trading level at $2.28 during the session, while it also had its lowest trading level at $2.13.
Ratios:
Our analysis of SNTI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.22 and its Current Ratio is at 4.22. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Laidlaw on June 06, 2025, initiated with a Buy rating and assigned the stock a target price of $5.
On October 07, 2022, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $7.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 04 ’25 when Lu Timothy K sold 3,922 shares for $4.07 per share. The transaction valued at 15,963 led to the insider holds 82,627 shares of the business.
Lu Timothy K sold 545 shares of SNTI for $2,376 on Feb 06 ’25. The CEO now owns 82,082 shares after completing the transaction at $4.36 per share. On Feb 04 ’25, another insider, Rajangam Kanya, who serves as the Pres. & Chief Med. & Dev. Off. of the company, sold 1,297 shares for $4.07 each. As a result, the insider received 5,279 and left with 8,803 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNTI now has a Market Capitalization of 55552744 and an Enterprise Value of 53601204.
Stock Price History:
The Beta on a monthly basis for SNTI is 2.10, which has changed by -0.3238095 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, SNTI has reached a high of $16.94, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is -25.34%, while the 200-Day Moving Average is calculated to be -36.13%.
Shares Statistics:
SNTI traded an average of 214.27K shares per day over the past three months and 95740 shares per day over the past ten days. A total of 26.00M shares are outstanding, with a floating share count of 7.97M. Insiders hold about 69.44% of the company’s shares, while institutions hold 12.76% stake in the company. Shares short for SNTI as of 1749772800 were 284129 with a Short Ratio of 2.85, compared to 1747267200 on 155580. Therefore, it implies a Short% of Shares Outstanding of 284129 and a Short% of Float of 1.0999999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are keenly observing as 2 analysts analyze and rate the current performance of Senti Biosciences Inc (SNTI) in the stock market.The consensus estimate for the next quarter is -$0.88, with high estimates of -$0.55 and low estimates of -$1.21.
Analysts are recommending an EPS of between -$2.34 and -$5.06 for the fiscal current year, implying an average EPS of -$3.7. EPS for the following year is -$2.13, with 2.0 analysts recommending between -$1.24 and -$3.02.
